BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 24745796)

  • 1. Statin use and the risk of recurrence after radical prostatectomy in a cohort of men with inherited and/or early-onset forms of prostate cancer.
    Ishak-Howard MB; Okoth LA; Cooney KA
    Urology; 2014 Jun; 83(6):1356-61. PubMed ID: 24745796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of statins and prostate cancer recurrence among patients treated with radical prostatectomy.
    Chao C; Jacobsen SJ; Xu L; Wallner LP; Porter KR; Williams SG
    BJU Int; 2013 May; 111(6):954-62. PubMed ID: 23464862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative Statin Use at the Time of Radical Prostatectomy Is Not Associated With Biochemical Recurrence or Pathologic Upgrading.
    Lyon TD; Turner RM; Yabes JG; Woldemichael E; Davies BJ; Jacobs BL; Nelson JB
    Urology; 2016 Nov; 97():153-159. PubMed ID: 27516122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postoperative statin use and risk of biochemical recurrence following radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database.
    Allott EH; Howard LE; Cooperberg MR; Kane CJ; Aronson WJ; Terris MK; Amling CL; Freedland SJ
    BJU Int; 2014 Nov; 114(5):661-6. PubMed ID: 24588774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of statin use on clinicopathological characteristics of localized prostate cancer and outcomes obtained after radical prostatectomy: a single center study.
    Cattarino S; Seisen T; Drouin SJ; Renard-Penna R; Leon P; Comperat E; Mozer P; Cussenot O; Rouprêt M
    Can J Urol; 2015 Apr; 22(2):7703-8. PubMed ID: 25891333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statin use after radical prostatectomy reduces biochemical recurrence in men with prostate cancer.
    Song C; Park S; Park J; Shim M; Kim A; Jeong IG; Hong JH; Kim CS; Ahn H
    Prostate; 2015 Feb; 75(2):211-7. PubMed ID: 25327522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aetiology and management of earlier vs later biochemical recurrence after retropubic radical prostatectomy.
    Llukani E; Lepor H
    BJU Int; 2017 Oct; 120(4):505-510. PubMed ID: 28220652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statins are Associated With Increased Biochemical Recurrence After Radical Prostatectomy in Diabetic Men but no Association was Seen in Men also Taking Metformin: Results From the SEARCH Database.
    Aminsharifi A; Howard LE; Amling CL; Aronson WJ; Cooperberg MR; Kane CJ; Terris MK; Polascik TJ; Freedland SJ
    Clin Genitourin Cancer; 2019 Feb; 17(1):e140-e149. PubMed ID: 30366879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early prostate-specific antigen relapse after radical retropubic prostatectomy: prediction on the basis of preoperative and postoperative tumor characteristics.
    Graefen M; Noldus J; Pichlmeier U; Haese A; Hammerer P; Fernandez S; Conrad S; Henke R; Huland E; Huland H
    Eur Urol; 1999; 36(1):21-30. PubMed ID: 10364651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statin use and risk of disease recurrence and death after radical prostatectomy.
    Keskiväli T; Kujala P; Visakorpi T; Tammela TL; Murtola TJ
    Prostate; 2016 Apr; 76(5):469-78. PubMed ID: 26689439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statin medication use and the risk of biochemical recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) Database.
    Hamilton RJ; Banez LL; Aronson WJ; Terris MK; Platz EA; Kane CJ; Presti JC; Amling CL; Freedland SJ
    Cancer; 2010 Jul; 116(14):3389-98. PubMed ID: 20586112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of statin use with pathological tumor characteristics and prostate cancer recurrence after surgery.
    Mondul AM; Han M; Humphreys EB; Meinhold CL; Walsh PC; Platz EA
    J Urol; 2011 Apr; 185(4):1268-73. PubMed ID: 21334020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of statin use on biochemical recurrence in patients treated with radical prostatectomy.
    Rieken M; Kluth LA; Xylinas E; Seitz C; Fajkovic H; Karakiewicz PI; Lotan Y; Briganti A; Loidl W; Faison T; Crivelli JJ; Scherr DS; Bachmann A; Tewari AK; Kautzky-Willer A; Pummer K; Shariat SF
    Prostate Cancer Prostatic Dis; 2013 Dec; 16(4):367-71. PubMed ID: 23999669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radical prostatectomy represents an effective treatment in patients with specimen-confined high pathological Gleason score prostate cancer.
    Lughezzani G; Gallina A; Larcher A; Briganti A; Capitanio U; Suardi N; Lista G; Abrate A; Sangalli MN; Buffi N; Cestari A; Guazzoni G; Rigatti P; Montorsi F
    BJU Int; 2013 May; 111(5):723-30. PubMed ID: 22487441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radical prostatectomy and positive surgical margins: relationship with prostate cancer outcome.
    De La Roca RL; Da Cunha IW; Bezerra SM; Da Fonseca FP
    Int Braz J Urol; 2014; 40(3):306-15. PubMed ID: 25010296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns and predictors of early biochemical recurrence after radical prostatectomy and adjuvant radiation therapy in men with pT3N0 prostate cancer: implications for multimodal therapies.
    Briganti A; Joniau S; Gandaglia G; Cozzarini C; Sun M; Tombal B; Haustermans K; Hinkelbein W; Shariat SF; Karakiewicz PI; Montorsi F; Van Poppel H; Wiegel T
    Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):960-7. PubMed ID: 24351411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-grade prostate cancer and biochemical recurrence after radical prostatectomy among men using 5α-reductase inhibitors and alpha-blockers.
    Murtola TJ; Kujala PM; Tammela TL
    Prostate; 2013 Jun; 73(9):923-31. PubMed ID: 23334943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statin use and risk of prostate cancer biochemical recurrence after radical prostatectomy.
    Prabhu N; Kapur N; Catalona W; Leikin R; Helenowski I; Jovanovich B; Gurley M; Okwuosa TM; Kuzel TM
    Urol Oncol; 2021 Feb; 39(2):130.e9-130.e15. PubMed ID: 33132024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood cholesterol, tumor clinical characteristics and risk of prostate cancer progression after radical prostatectomy.
    Rantaniemi L; Tammela TLJ; Kujala P; Murtola TJ
    Scand J Urol; 2018 Aug; 52(4):269-276. PubMed ID: 30362865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.
    Ploussard G; Agamy MA; Alenda O; Allory Y; Mouracade P; Vordos D; Hoznek A; Abbou CC; de la Taille A; Salomon L
    BJU Int; 2011 Jun; 107(11):1748-54. PubMed ID: 20883488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.